Innate signals from Nod2 block respiratory tolerance and program TH2-driven allergic inflammation

We show that a Nod-like receptor is a novel, previously unrecognized, pathway that adversely links innate and adaptive immunity and leads to allergic disease and asthmatic lung inflammation.